Zeway Report
Zeway Report
Zeway Report
A research report on
January 2019
Addis Ababa, Ethiopia.
List of abrvation and acronyms
Abstract
Background:
Drug utilization research was defined by WHO in 1977 as «the marketing, distribution,
prescription, and use of drugs in a society, with special emphasis on the resulting medical, social
and economic consequences»(1).
Despite the fact that the most leading causes of death and disability in developing countries can
be prevented, treated or at least alleviated with cost effective drugs, many people do not have
regular access to essential drugs. On the top of that those who have access are using drugs
irrationally [1]
Method
A cross-sectional study was carried out by sampling 384 prescriptions from all
prescriptions of the pharmacy of the abosa health center from aprill 2018 to juanuary 2019.
A systematic random sampling technique was employed to select prescriptions during data
collection. Data processing and analyzing was done by scientific calculators and by using
computers software.
Result
Out of 384 prescriptions analyzed, a total of 836 drug products were prescribed. The average
number of drugs per prescription was 2.1. The total number of drugs prescribed by generic name
was (99.3%). Antibiotics were prescribed in 331(86.19%) encounters and injections were
prescribed in 76(19.7%) encounters. All drugs prescribed were from essential drug list of
Ethiopia
Conclusion
The finding of this study revealed that drug utilization pattern was not optimal in accordance
with the standard values of WHO prescribing indicators. There was over prescription of
antibiotics and a higher tendency of poly pharmacy
1.Background
Drug utilization research was defined by WHO in 1977 as «the marketing, distribution,
prescription, and use of drugs in a society, with special emphasis on the resulting medical, social
and economic consequences»(1).
Despite the fact that the most leading causes of death and disability in developing countries can
be prevented, treated or at least alleviated with cost effective drugs, many people do not have
regular access to essential drugs. On the top of that those who have access are using drugs
irrationally [1]
WHO developed Medication Use Indicators, including Prescription Indicators with aim to
evaluate the services provided to the population in regards to medications Prescription
Indicators allow the therapeutic actions taken in similar institutions to be ascertained, enabling
subsequent comparison of parameters between them, and to evaluate the population’s medication
needs and determine the most frequently used medications in a given place [1]. In addition, these
indicators enable the investigator to identify the prescription profile and quality of services
offered to the population.The prescription Indicators are as follows (2)
Average number of drugs per medical prescription This indicator helps in investigating poly-
medication, which is a major factor contributing to adverse drug reactions (ADRs) and drug-drug
interactions (DDIs). The educational quality informational level of the prescriber may also be
observed (2).
Percentage of drugs prescribed by generic name This indicator enables the investigator to
calculate the number of prescriptions in which the drugs are prescribed by the generic name. This
helps in controlling drug costs in the health service. It also evaluates the marketing influence on
the person prescribing drugs (2).
Percentage of prescribed injectable drugs This indicator helps to evaluate the injectables in
excess, administration of which may have serious consequences when prescribed or applied
wrongly, such as in the event of anaphylactic reactions, adverse reactions, necrosis, etc(2).
Percentage of encounters with an antibiotic prescribed This indicator evaluates the use of
antibiotics in excess which contributes to bacterial dissemination and resistance
Percentage of drugs prescribed from essential drug list or formulary This indicator helps in
measuring the degree to which practices conform to the current National Drug Policy (2)
The sampling method was systematic random sampling. The sample size was 384
prescription, which is found by calculating using simple proportion formula
2.6Study population
Randomly selected prescription in abosa health center from 1/1/10 to 30/12/10
2.7 Eligibility.
Inclusion criteria
Exclusion criteria
First the collected data were check for completeness. Then the collected data where interred on
software (EpiData) then I convert the entered data to Microsoft excel and I analyzed the data..
Variables considered in the data analysis include
1. Average number of drugs per encounter
2. Percentage of encounters with an antibiotic prescribed.
3. Percentage of encounters with an injection prescribed.
4. Percentage of drugs prescribed from essential dru
Ethical clearance will be obtained from the ethical review board of School of public health,
College of Health Sciences, Addis Ababa University. Information obtained from all data
collection techniques in the course of study will only be handled by research team, and data will
be analyzed in aggregates.
Result
Out of 384 prescriptions analyzed, a total of 836 drug products were prescribed. The average
number of drugs per prescription was 2.1. The total number of drugs prescribed by generic name
was (99.3%). Antibiotics were prescribed in 331(86.19%) encounters and injections were
prescribed in 76(19.7%) encounters. All drugs prescribed were from essential drug list of
Ethiopia (Table 1).
Table 1:drug prescribing indicator in abosa health center from aprill 2018 to juanuary 2019.
(N=384)
Table 2: top five prescribed drugs from aprill 2018 to juanuary 2019. (N=384)
Diclofenac 80 9.5%
Ciprofloxacin 56 6.6%
Doxycycline 47 5.6%
Table 3: top three antibiotics prescribed from aprill 2018 to juanuary 2019. (N=384)
Ciprofloxcillin 56 13.8%
Doxycycline 47 11.6%
DISCUSSION
CONCLUSION
The finding of this study revealed that drug utilization pattern was not optimal in
accordance with the standard values of WHO prescribing indicators. There was
over prescription of antibiotics and a higher tendency of poly pharmacy.